Healing of leishmaniasis-a parasitic skin disease-is associated with high levels of secreted interferon (IFN)γ and IL-12 in resistant C57BL/6 mice and humans. Susceptible BALB/c mice predominantly react with a Th17/Th2/Treg-related immune response and finally succumb to infection. Previously, we showed that BALB/c IL-17A
| BACKGROUND
Leishmaniasis is a parasitic skin disease transmitted by sand flies.
Inside skin, infectious-stage promastigotes are taken up by macrophages (MΦ) and neutrophils, [S1] transform into intracellular amastigotes and are finally released into the surrounding tissue. [1] Free amastigotes are then ingested by other immune cells, for example dendritic cells (DC), which migrate to draining lymph nodes (LN) secreting IL-12p40 thereby priming T cells. Upon activation, CD4 + and CD8 + T cells relocate to sites of infection and release IFNγ, which in turn leads to upregulation of nitric oxide in infected MΦ, finally killing the parasite. [1] Depending on the immune status of the host, infections with Leishmania lead to self-healing lesions accompanied by increased levels of IFNγ and IL-12p40 and long-lasting immunity-for example in C57BL/6 mice and immunocompetent humans. On the other hand, in immunosuppressed patients or BALB/c mice, infections
with Leishmania result in predominant Th2 immune responses with increased levels of IL-4 and IL-10. [1] [2] [3] , [S1]
IL-23-a member of the IL-12 family-is a heterodimeric protein consisting of the subunits p19 and p40 and is released by various cell types including DC and MΦ. IL-23 promotes the expansion and survival of IL-17A producing CD4 + Th17 cells. [4, 5] Previously, we
showed that the Th17/IL-23 axis is not involved in clearance of L.
major infections in resistant C57BL/6 mice. Both IL-17A −/− and IL23p19 −/− C57BL/6 mice developed similar lesion volumes, local and systemic parasite burdens and cytokine levels compared to control mice. [6] In contrast, IL-17A levels are highly increased in susceptible BALB/c mice upon infection with L. major, [3] and IL-17A −/− BALB/c mice were protected from progressive disease, [3] indicating that IL-17A plays a critical role for disease outcome in BALB/c mice. In this setting, IL-17A was primarily produced by CD4 + T cells and neutrophils. [3, 7] Induction of Th17 cells depends on DC-derived IL-23, IL-1,
TGFβ and IL-6. In first experiments, we identified higher amounts of IL-23p19 and IL-6, but not TGFβ, in supernatants of LN cells from infected BALB/c mice.
[3]
| QUESTION ADDRESSED
To address which of these Th17-inducing cytokines is relevant in progressive leishmaniasis, we now generated IL-23p19 −/− mice on BALB/c background.
| EXPERIMENTAL DESIGN
In brief, marker-assisted speed congenic IL-23p19 −/− BALB/c mice were generated. Sixty-two PCR primer pairs for amplification of at least two microsatellite markers per chromosome were chosen with at least 10-bp different polymorphic bands: PCR products were amplified from mouse tail biopsy DNA and analysed by electrophoresis in 3% agarose gels (Phor Agarose, Biozyme Scientific, Germany) and a gel distance of 12 centimetres from the loading wells. [8, 9] All markers were chosen from the Mouse Genome Informatics Database. 
| RESULTS

IL-23p19
| CONCLUSIONS
Interestingly, IL-17A production was almost absent in infected IL- 
